Released Jul 18, 2024, after the close
10-Q filed Jul 19, 2024, 19 days after period end · 0001035267-24-000207
Q2 2024 · 10-Q
Revenue$2.01B$2.01B +14.5% vs Q2 2023+6.3% vs Q1 2024
Net Income$526.90M$526.90M +25.2% vs Q2 2023−3.3% vs Q1 2024
EPS Diluted$1.46$1.46 +23.7% vs Q2 2023−3.3% vs Q1 2024
Gross Profit$1,372,700,000+17.1%
Operating Income$567,300,000+22.5%
Operating Cash Flowderived$620,500,000−6.8%
Free Cash Flowderived$311,100,000−36.2%
Margins · derived
Gross margin68.3%+1.6 pt vs Q2 2023
Operating margin28.2%+1.8 pt vs Q2 2023
Net margin26.2%+2.3 pt vs Q2 2023
What the release said
The release
Same quarter
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $2.01B | $1.76B | $1.52B | $1.46B |
| Net Income | $526.90M | $420.80M | $307.80M | $517.20M |
| EPS Diluted | $1.46 | $1.18 | $0.85 | $1.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR